Citigroup
LGND icon

Citigroup’s Ligand Pharmaceuticals LGND Stock Holding History

Citigroup’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-20,038
Closed -$1.24M – 6906
2020
Q4 		$1.24M Buy
20,038
+15,389
+331% +$877K ﹤0.01% 3323
2020
Q3 		$276K Sell
4,649
-7,854
-63% -$536K ﹤0.01% 4355
2020
Q2 		$872K Sell
12,503
-2,726
-18% -$173K ﹤0.01% 3698
2020
Q1 		$691K Sell
15,229
-10,579
-41% -$600K ﹤0.01% 3557
2019
Q4 		$1.68M Buy
25,808
+3,366
+15% +$225K ﹤0.01% 3189
2019
Q3 		$1.39M Buy
22,442
+19,396
+637% +$1.22M ﹤0.01% 3273
2019
Q2 		$217K Sell
3,046
-5,771
-65% -$425K ﹤0.01% 5188
2019
Q1 		$691K Sell
8,817
-4,167
-32% -$316K ﹤0.01% 3818
2018
Q4 		$1.1M Buy
12,984
+9,938
+326% +$1.06M ﹤0.01% 3298
2018
Q3 		$522K Sell
3,046
-5,290
-63% -$798K ﹤0.01% 4229
2018
Q2 		$1.08M Sell
8,336
-10,259
-55% -$1.14M ﹤0.01% 3283
2018
Q1 		$1.92M Buy
18,595
+13,946
+300% +$1.38M ﹤0.01% 2632
2017
Q4 		$397K Buy
4,649
+3,206
+222% +$278K ﹤0.01% 4341
2017
Q3 		$123K Sell
1,443
-44,563
-97% -$3.53M ﹤0.01% 5401
2017
Q2 		$3.48M Buy
46,006
+44,884
+4,000% +$3.14M ﹤0.01% 2030
2017
Q1 		$74K Sell
1,122
-21,801
-95% -$1.43M ﹤0.01% 5430
2016
Q4 		$1.45M Buy
22,923
+18,595
+430% +$1.17M ﹤0.01% 3297
2016
Q3 		$276K Buy
+4,328
New +$318K ﹤0.01% 4408

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Citigroup's LGND Position: Q1 2026 in Review

Citigroup increased its Ligand Pharmaceuticals (LGND) stake by 18% in Q1 2026, buying an estimated $653K and bringing the position to 21,594 shares worth $4.31M. The position accounts for ﹤0.01% of the portfolio, ranked #2081.

Citigroup first reported a position in LGND in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.61M in Q4 2016. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • Citigroup held 21,594 shares of Ligand Pharmaceuticals worth $4.31M as of Q1 2026.
  • Citigroup bought 3,302 Ligand Pharmaceuticals shares in Q1 2026, an estimated $653K.
  • Ligand Pharmaceuticals made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #2081 holding.
  • Citigroup first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Ligand Pharmaceuticals position peaked at $8.61M in Q4 2016.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.